The prevalence of suicide risk in people living with inflammatory bowel diseases in southern Brazil
DOI:
https://doi.org/10.11606/issn.1679-9836.v103i6e-225106Keywords:
People living with Crohn's disease, People living with ulcerative colitis, Suicide risk associated with inflammatory bowel diseases, Psychiatric disorders in inflammatory bowel diseaseAbstract
The present article is a cross-sectional, observational, and descriptive study that aimed to assess the prevalence of suicide risk in individuals living with Crohn's disease and ulcerative colitis who were treated at a gastroenterology clinic in southern Brazil. This study was part of a larger research project that evaluated the prevalence of depression and anxiety in patients with inflammatory bowel disease. The research utilized data from medical records, sociodemographic questionnaires, and adapted versions of the Mini International Neuropsychiatric Interview based on the Diagnostic and Statistical Manual of Mental Disorders of the American Psychiatric Association, focusing on anxiety, depression, and suicide risk. These were assessed during interviews conducted during medical consultations from July 2021 to February 2022. The statistical analysis of the data was performed using SPSS 21.0. The results showed that suicide risk was present in 25.4% of the sample, with 86.7% of these individuals living with Crohn's disease, highlighting the importance of mental health in these patients and the need for multidisciplinary care with an emphasis on psychosocial factors.
Downloads
References
SPX, Diagnóstico por imagem. Doença de Crohn e a Demora do Diagnóstico. https://spximagem.com.br/a-doenca-de-crohn-e-a-demora-do-diagnostico
Brenner M. Sobre a Doença de Crohn. http://www.abcd.org.br/sobre-a-doenca-de-crohn/
Walfish A. Doença de Crohn. https://www.msdmanuals.com/pt-br/profissional/dist%C3%BArbios-gastrointestinais/doen%C3%A7a-inflamat%C3%B3ria-intestinal/doen%C3%A7a-de-crohn
Fleury, Medicina e Saúde. Passo a passo na descoberta e diagnóstico da Doença de Crohn. https://infusoes.fleury.com.br/blog/o-passo-a-passo--=p-[}+a--descoberta-e-diagnostico-da-doenca-de-crohnm
Valles-Colomer M, Falony G, Darzi Y, Tigchelaar EF, Wang J, Tito RY, et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019;4:623-32 Doi: https://doi.org/10.1038/s41564-018-0337-x
Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet. 2021;6(5): 359-70 Doi: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00014-5/fulltext
Gibson PR, Weston AR, Shann A, Florin TH, Lawrance IC, Macrae FA, Radford-Smith G. Relationship between disease severity, quality of life and health-care resource use in a cross-section of Australian patients with Crohn's disease. J Gastroenterol Hepatol. 2007;22(8):1306-12. Doi: 10.1111/j.1440-1746.2007.04930.x
Luo J, Zhongwei X, Raymond N, Diana van Heemst, Ruifang L. Depression and Inflammatory Bowel Disease: A Bidirectional Two-sample Mendelian Randomization Study, J Crohn's and Colitis. 2022;16(4):633-42 Doi: https://doi.org/10.1093/ecco-jcc/jjab191
Facanali CBG, Sobrado Jr CW, Fraguas Jr R, Facanali Jr MR, Boarini LR, Sobrado LF, Ceccpnello I. The relationship of major depressive disorder with Crohn's disease activity. Clinics. 2023(78):100188 Doi: https://doi.org/10.1016/j.clinsp.2023.100188
Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm. Bowel Dis. 2016;22:752-62. Doi: https://doi.org/10.1097/MIB.0000000000000620
Lecrubier Y, Weiller E, Hergueta T, Amorim P, Bonora LI, Lépine JP, et al. Mini International Neuropsychiatric Interview Brazilian version 5.0.0 DSM IV. Disponivel em: https://www.cosemssp.org.br/downloads/Cursos/Saude-Mental-DSM-07-03.pdf
American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. Washington, DC: American Psychiatric Publishing.
Harbord M, Eliakim R, Bettenworth D, Karmiris K, Katsanos K, Kopylov U, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. J Crohn´s Colitis. 2017;11(7):769-84 Doi: https://doi.org/10.1093/ecco-jcc/jjx009.
Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Acosta MB, et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. J Crohn's Colitis. 2017;11(6):649-70 Doi: https://doi.org/10.1093/ecco-jcc/jjx008.
Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. Third European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease. J Crohn's Colitis. 2017;11(1):3-25 Doi: https://doi.org/10.1093/ecco-jcc/jjw168.
Torres J, Caprioli F, Katsanos KH, Pane S, Zilli A, Kopylov U, et al. Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases. J Crohns Colitis. 2016;10(12):1385-94 Doi: https://doi.org/10.1093/ecco-jcc/jjw116.
Selinger CP, Lal S, Eaden J, Hamilton MI, Lobo AJ, Lewis A, et al. Better disease specific patient knowledge is associated with greater anxiety in inflammatory bowel disease. J Crohn´s Colitis. 2013;7(6):214-8 https://doi.org/10.1016/j.crohns.2012.09.014.
Mendonça CM, Neto IJFC, Rolim AS, Robles L. Inflamatory Bowel Diseases: Caractheristics, Evolution and quality of life. ABCD. 2022;35. https://doi.org/10.1590/0102-672020210002e1653
Secretaria da Saúde, Curitiba. Ansiedade. https://bvsms.saude.gov.br/ansiedade/
Dinan TG, Cryan JF. The microbiome-gut-brain axis in health and disease. Gastroenterol Clin North Am. 2017;46(1):77-89. 2017/02/07. Doi: https://doi.org/10.1016/j.gtc.2016.09.007
Osadchiy V, Martin CR, Mayer EA. The gut-brain axis and the microbiome: mechanisms and clinical implications. Clin. Gastroenterol. Hepatol. 2019;17:322-32. Doi: https://doi.org/ 10.1016/j.cgh.2018.10.002
Voet S, Mc Guire C, Hagemeyer N, Martens A, Schoeder A, Wieghofer P, et al. A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation. Nat. Commun. 2018;9(1):2036. Doi: https:// doi.org/10.1038/s41467-018-04376-5
Walker KA, Gottesman RF, Wu A, Knopman DS, Gross AL, Mosley Jr TH, et al. Systemic inflammation during midlife and cognitive change over 20 years: the ARIC study. Neurology 2019;92(11): e1256-67. Doi: https://doi.org/10.1212/WNL.0000000000007094
Zhang B, Nakamura BN, Perlman A, Alipour O, Abbasi SQ, Sohn P, et al. Identification of functional missense single-nucleotide polymorphisms in TNFAIP3 in a predominantly Hispanic population. J. Clin. Transl. Sci. 2018;2(6):350-5. https://doi.org/10.1017/cts.2019.3
Ludvigsson JF, Olén O, Larsson H, Halfvarson J, Almqvist C, et al. Association between inflammatory bowel disease and psychiatric morbidity and suicide: A Swedish nationwide population-based cohort study with sibling comparisons. J Crohn’s Colitis. 2021;15(11):1824-36 Doi: 10.1093/ecco-jcc/jjab039.
Wang YP, Zhang B, Wang HE, Bai YM, Tsai SJ, Chen TJ, Chen MH. Risk of Attempted Suicide Among Patients With IBD: A Nationwide Longitudinal Follow-up Study. Dis Colon Rectum. 2023;66(9):e938-e945. Doi: 10.1097/DCR.0000000000002705
World Health Organization, Geneva (2017). Depression and Other Common Mental Disorders: Global Health Estimates. https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER-2017.2-eng.pdf.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Gabriel Canhete Machado, João Hélio Alvez Marciano Neto, Pedro Henrique Caetano Santos, Elza Cristina Miranda da Cunha Bueno
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
